Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Edgewise Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 214
- +20 vs. Q4 2025
- Shares held
- 118.5M
- +2.37M (+2.0%) vs. Q4 2025
- Total value
- $3.72B
- +$839.3M (+29.1%) vs. Q4 2025
- New holders
- 44
- 65 more added
- Sold out
- 24
- 66 more reduced
5 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.82B |
| Q1 2026 | 214 | $3.72B |
| Q4 2025 | 199 | $3.02B |
| Q3 2025 | 173 | $1.82B |
| Q2 2025 | 179 | $1.56B |
| Q1 2025 | 193 | $2.32B |
| Q4 2024 | 201 | $2.64B |
| Q3 2024 | 177 | $2.71B |
| Q2 2024 | 140 | $1.83B |
| Q1 2024 | 129 | $1.67B |
| Q4 2023 | 116 | $871.4M |
| Q3 2023 | 85 | $392.2M |
| Q2 2023 | 95 | $538.8M |
| Q1 2023 | 85 | $443.1M |
| Q4 2022 | 90 | $594.1M |
| Q3 2022 | 94 | $633.5M |
| Q2 2022 | 78 | $405.7M |
| Q1 2022 | 72 | $523.5M |
| Q4 2021 | 58 | $769.4M |
| Q3 2021 | 48 | $795.8M |
| Q2 2021 | 46 | $1.03B |
| Q1 2021 | 31 | $1.48B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Edgewise Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 2,246,028 | $70.7M | 0.00% | −664,853−22.8% | Reduced |
| Braidwell LP | 2,347,583 | $73.9M | 2.47% | −2,863,248−54.9% | Reduced |
| Cormorant Asset Management, LP | 3,260,000 | $102.7M | 5.18% | −25,000−0.8% | Reduced |
| Vanguard Capital Management LLC | 3,788,161 | $119.3M | 0.00% | +3,788,161 | New |
| Perceptive Advisors LLC | 4,423,974 | $139.4M | 2.75% | −34,000−0.8% | Reduced |
| Siren, L.L.C. | 4,430,263 | $139.6M | 3.87% | −99,727−2.2% | Reduced |
| Driehaus Capital Management LLC | 4,477,942 | $141.1M | 1.04% | +286,749+6.8% | Added |
| Novo Holdings A/S | 5,350,000 | $168.5M | 13.65% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 5,915,556 | $186.3M | 0.09% | +1,348,706+29.5% | Added |
| BlackRock, Inc. | 6,472,991 | $203.9M | 0.00% | −157,585−2.4% | Reduced |
| Baker Bros. Advisors LP | 6,575,940 | $207.1M | 1.19% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 7,365,038 | $232.0M | 4.74% | +823,828+12.6% | Added |
| Ra Capital Management, L.P. | 10,428,437 | $328.5M | 3.48% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 15,518,492 | $488.8M | 11.11% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −765,694−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −337,340−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −151,905−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −100,046−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −79,915−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −41,584−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −33,591−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Optimize Financial Inc | 0 | $0 | 0.00% | −27,679−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −18,672−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −14,184−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −14,085−100.0% | Sold out |
| VARCOV Co. | 0 | $0 | 0.00% | −10,034−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −9,849−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −9,468−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −7,143−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −3,900−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,120−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −774−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −489−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −344−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| Oracle Investment Management Inc | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |